News|Videos|July 14, 2025
Your Opinion About Long-Acting PrEP: Fortune Effiong, Nigeria | IAS 2025
Author(s)Peter Wehrwein, Managing Editor
Advertisement
We asked people attending the International AIDS Society meeting in Kigali, Rwanda, their opinion about long-acting injectable HIV preexposure prophylaxis and what it could mean for HIV prevention. Fortune Effiong, a researcher at the University of Calabar Teaching Hospital in Nigeria, shared his views about the potential of self-injectable versions of PrEP.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
House passes funding bill that includes PBM reform
2
Medicare’s first-year payments for social needs showed high use by primary care but many claims were denied
3
A conversation about improving PrEP uptake in New York City with Emma Kaplan-Lewis, M.D., clinical quality director for HIV, hepatitis and sexual health services at NYC Health + Hospitals
4
Congress challenges health insurers saying they put profits over patients
5



























